Cintas Corporation (CTAS) Stock Price Today
Abivax gains FDA nod for Obefazimod, backed by strong cash and positive analyst outlook.
Abivax received positive pre-NDA feedback from the U.S. FDA for its drug Obefazimod, marking a key step in its development. Despite a recent price target cut by Wedbush to $118, analysts maintain a "Moderate Buy" consensus with an average target of $...
Netflix stock downgraded by HSBC and Wells Fargo over falling viewer engagement.
HSBC and Wells Fargo have downgraded Netflix stock due to declining subscriber engagement and an 8% drop in viewership time. Despite a recent 2.19% stock gain, Netflix shares have fallen over 40% in the past year amid strong competition and weaker or...
FormFactor director sells 2,100 shares, signaling insider stock movement
A director at FormFactor sold 2,100 shares, indicating a notable insider transaction. Such sales can reflect personal financial decisions or strategic portfolio adjustments by company insiders. Investors often watch these moves for potential signals ...
Cintas expects Q3 EPS of $1.35 and revenue of $2.98B, driven by strong demand and acquisitions.
Cintas Corporation is set to report its Q3 earnings with an expected EPS of $1.35 and revenue of $2.98 billion, up from $2.72 billion last year. The growth is supported by strong customer retention, increased demand for services like AED Rentals, and...
Meta stock jumps 11.3% on AI assistant Muse topping Apple's U.S. App Store.
Meta Platforms' stock surged 11.3% following strong investor enthusiasm for its new AI assistant, Muse, which became the top free app on Apple's U.S. App Store. This success boosts optimism that Meta can develop new AI-driven revenue streams beyond i...
China's gold imports hit record high in August, pushing 2026 total past 1,100 tonnes amid strong demand.
China's gold imports reached a monthly high in August, contributing to a record total of over 1,100 tonnes for 2026 so far, surpassing the entire 2025 imports. Strong investment demand, a robust yuan, and increased approval quotas have made gold impo...
Moderna stock jumps 5%, up 500% in 2026 ahead of key cancer therapy data release.
Moderna's stock surged 5% to $181.51, marking a 516% gain in 2026, driven by anticipation of late-October Phase 3 data for its personalized cancer therapy, intismeran autogene, developed with Merck. The therapy targets high-risk melanoma patients and...
Berkshire Hathaway boosts Alphabet stake 83%, signaling strong confidence in AI-driven growth.
Berkshire Hathaway increased its investment in Alphabet by 83%, making it the company's third-largest holding. This move highlights confidence in Alphabet's transition into a capital-intensive AI infrastructure leader, supported by strong financials ...
Lennar reports weak Q3 with 48% EPS drop, cuts home delivery guidance but remains a Buy at $76.43 target $94.
Lennar Corporation experienced a challenging third quarter, reporting $8.05 billion in revenue and a 48% year-over-year decline in adjusted EPS to $1.23. New home orders fell 9%, prompting management to lower full-year home delivery guidance. Despite...
Mastercard and SoFi launch stablecoin settlement for SoFi's $25B card program, enabling instant, cost-free merchant payouts.
Mastercard and SoFi Technologies have introduced stablecoin settlement for SoFi Bank's $25 billion debit and credit card program using SoFiUSD, a U.S. dollar-backed stablecoin. This allows merchants to receive instant settlement funds with zero withd...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.